Michael Dickinson, MBBS, DMedSc, FRACP, FRACPA

Articles by Michael Dickinson, MBBS, DMedSc, FRACP, FRACPA

Michael Dickinson, MBBS, DMedSc, FRACP, FRACPAMultimedia | January 20, 2023
Michael Dickinson, MBBS, DMedSc, discusses trials in progress that are evaluating glofitamab with other agents for DLBCL.
View More
Michael Dickinson, MBBS, DMedSc, FRACP, FRACPAMultimedia | January 18, 2023
Michael Dickinson, MBBS, DMedSc, discusses a phase II trial of glofitamab, a bispecific antibody, in patients with DLBCL.
Michael Dickinson, MBBS, DMedSc, FRACP, FRACPAMultimedia | January 13, 2023
Michael Dickinson, MBBS, DMedSc, discusses updates on glofitamab that were presented during the 2022 ASH meeting.